About me
I am from an IVD regulatory team supporting drug programs, now building our digital health capabilities. I’m here to learn what works for digital endpoints and SaMD—validation, data quality, and fit‑for‑purpose evidence—and to hear pragmatic paths to FDA, EMA, and IVDR acceptance.
LinkedIn